4298
I. J. S. Fairlamb et al. / Bioorg. Med. Chem. 12 (2004) 4285–4299
15. (a) Shi, X.; Leal, W. S.; Liu, Z.; Schrader, E.; Meinwald, J.
Tetrahedron Lett. 1995, 36, 71; (b) Leal, W. S.; Shi, X.;
Liang, D.; Schal, C.; Meinwald, J. Proc. Natl. Acad. Sci.
U.S.A. 1995, 92, 1033.
16. (a) Danieli, B.; Lesma, G.; Martinelli, M.; Passarella, D.;
Peretto, I.; Silvani, A. Tetrahedron 1998, 54, 14081; (b)
Liu, Z.; Meinwald, J. J. Org. Chem. 1996, 61, 6693.
17. Waldmann, H. Bioorg. Med. Chem. 2003, 11, 3045.
Labsystems UK Ltd.) at 540 nm with subtraction at
620 nm to allow for turbidity. The resultant output was
processed and the percentage growth inhibition for each
dose calculated, each experiment was performed in
duplicate. Mean and standard deviations for each dose
were calculated from duplicate experiments. Based on a
standard assay.54
~
18. Cervera, M.; Moreno-manas, M.; Pleixats, R. Tetrahedron
1990, 46, 7885.
7.2. Antimicrobial assay
19. Kato, Y.; Okada, S.; Tomimoto, K.; Mase, T. Tetrahedron
Lett. 2001, 42, 4849.
20. Negishi, E.; Anastasia, L. Chem. Rev. 2003, 103, 1979.
21. Fairlamb, I. J. S.; Lu, F.-J.; Schmidt, J.-P. Synthesis 2003,
2564.
22. Beletskaya, I. P.; Cheprakov, A. V. Chem. Rev. 2000, 100,
3009.
23. Takia, K.; Sato, M.; Oshima, A.; Nozaki, H. Bull. Chem.
Soc. Jpn. 1984, 57, 108.
24. Baba, S.; Negishi, E. J. Am. Chem. Soc. 1976, 98, 6729.
25. Miyaura, N.; Suzuki, A. Chem. Commun. 1979, 866.
26. Negishi, E.; Valente, L. F.; Kobayashi, M. J. Am. Chem.
Soc. 1980, 102, 3298.
27. Hatanaka, Y.; Ebina, Y.; Hiyama, T. J. Am. Chem. Soc.
1991, 113, 7075, and references cited therein.
28. Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 25, 508.
29. Negishi, E.; Takahashi, T.; Baba, S.; Van Horn, D. E.;
Okukado, N. J. Am. Chem. Soc. 1987, 109, 2393.
30. Negishi, E.; Van Horn, D. E. J. Am. Chem. Soc. 1978, 100,
2252.
The antimicrobial assays were performed as previously
described.55 An antibiotic ‘ring’, which contained several
known potent antibacterial agents (Novobiocin, Peni-
cillin G, Streptomycin, Tetracyline, Chloroamphenicol,
Erythromycin, Fusidic acid and Methicillin), was used
as the control in the bacterial assays (individual discs
contain 1 unit). Zones of inhibition (ꢀ5–8 mm) were
observed for these compounds. Squalestatin S1 (Zar-
agozic acid A), an extremely potent yeast inhibitor, was
used as a control in the yeast assay (200 lg/disk). The
zones of inhibition observed against C. albicans, Sac-
charomyces cerevisiae and Schizosaccharomyces pombe
were 27, 27 and 37 mm, respectively.
References and notes
31. Negishi, E.; Okukado, N.; King, A.; Spiegel, B. I.; Van
Horn, D. E. J. Am. Chem. Soc. 1978, 100, 2254.
32. (a) Miyaura, N. J. Organomet. Chem. 2002, 653, 54; (b)
Suzuki, A. Acc. Chem. Res. 1982, 15, 178; (c) Suzuki, A.
Pure Appl. Chem. 1985, 57, 1749; (d) Miyaura, N.; Suzuki,
A. Chem. Rev. 1995, 95, 2457; (e) Stanforth, S. P.
Tetrahedron 1998, 54, 263.
33. (a) Wolfe, J. P.; Singer, R. A.; Yang, B. H.; Buchwald, S.
L. J. Am. Chem. Soc. 1999, 121, 9550; (b) Wolfe, J. P.;
Buchwald, S. L. Angew. Chem., Int. Ed. 1999, 38, 2413.
34. Brown, H. C.; Gupta, S. K. J. Am. Chem. Soc. 1975, 97,
5249.
1. Staunton, J. In Comprehensive Organic Chemistry; Burton,
D. H., Ollis, W. D., Eds.; Pergamon: New York, 1979;
p 629.
2. Moreno-Manas, M.; Pleixats, R. Naturally Occurring
Oxygen Ring Systems; Academic: New York, 1992; p 21.
3. Altomare, C.; Perrone, G.; Zonno, M. C.; Evidente, A.;
Pengue, R.; Fanti, F.; Polonelli, L. J. Nat. Prod. 2000, 63,
1131.
4. Dickinson, J. M. Nat. Prod. Rep. 1993, 10, 71.
5. Uen, Y. In Mycotoxins; Purchase, I. F. H., Ed.; Elsevier:
New York, 1974; p 283.
35. Wailes, P. C.; Weigold, H.; Bell, A. P. J. Organomet.
Chem. 1967, 8, 239.
6. Spencer, H. C.; Rowe, K.; McCollister, D. D. J. Pharma-
col. Exp. Ther. 1950, 99, 57.
36. Schwartz, J. J. Organomet. Chem. Libr. 1976, 1, 461.
37. Okukado, N.; Van Horn, D. E.; Klima, W. L.; Negishi, E.
Tetrahedron Lett. 1978, 19, 1027.
38. Brown, H. C. Organic Synthesis via Boranes; New York:
Wiley, 1975.
7. Tringali, C.; Parisi, A.; Piatelli, M.; Di San Lio, G. Nat.
Prod. Lett. 1993, 3, 101.
8. Hansen, O. R. Acta Chem. Scand. 1954, 8, 1332.
9. (a) Bu’Lock, J. D.; Smith, H. E. J. Chem. Soc. 1960, 1,
502; (b) Effenberger, F.; Ziegler, T. Chem. Ber. 1987, 120,
1339; (c) Tam, T. F.; Coles, P. Synthesis 1988, 383; (d)
Moody, C. J.; Rahimtoola, K. F. J. Chem. Soc., Perkin
Trans. 1 1990, 673; (e) Moody, C. J.; Rahimtoola, K. F.
J. Chem. Soc., Perkin Trans. 1 1990, 681.
10. (a) Afridi, A. S.; Katritzky, A. R.; Ramsden, C. A.
J. Chem. Soc., Perkin Trans. 1 1977, 1428; (b) Kiang, A.
K.; Tang, S. F.; Wang, W. S. J. Chem. Soc. 1971, 1, 2721.
11. (a) Lee, J.-H.; Kim, W.-S.; Lee, Y. Y.; Cho, C.-G.
Tetrahedron Lett. 2002, 43, 5779; (b) Lee, J.-H.; Park,
J.-S.; Cho, C.-G. Org. Lett. 2002, 4, 1171.
39. Castle, P. L.; Widdowson, D. A. Tetrahedron Lett. 1986,
27, 6013.
40. (a) Perchellet, E. M.; Ladesich, J. B.; Chen, Y.; Sin, H. S.;
Hua, D. H.; Kraft, S. L.; Perchellet, J. P. Anticancer Drugs
1998, 565; (b) Perchellet, J. P.; Newell, S. W.; Ladesich, J.
B.; Perchellet, E. M.; Chen, Y.; Hua, D. H.; Kraft, S. L.;
Basaraba, R. J.; Omura, S.; Tomoda, H. Anticancer Res.
1997, 1, 2427.
41. A variety of E-chalcones have been reported with potent
inhibitory activity against the K562 cell line, see: Ducki,
S.; Forrest, R.; Hadfield, J. A.; Kendall, A.; Lawrence, N.
J.; McGown, A. T.; Rennison, D. Bioorg. Med. Chem.
Lett. 1998, 8, 1051, For references relating to inhibitory
activity against the A2780 cell line, see: (a) McClusky, A.;
Bowyer, M. C.; Collins, E.; Sim, A. T. R.; Sakoff, J. A.;
Baldwin, M. L. Bioorg. Med. Chem. Lett. 2000, 10, 1687;
~
12. Cerezo, S.; Moreno-manas, M.; Pleixats, R. Tetrahedron
1998, 54, 7813.
13. Bellina, F.; Biagetti, M.; Carpita, A.; Rossi, R. Tetrahe-
dron Lett. 2001, 42, 2859.
14. (a) Marrison, L. R.; Dickinson, J. M.; Fairlamb, I. J. S.
Bioorg. Med. Chem. Lett. 2002, 12, 3509; (b) Marrison, L.
R.; Dickinson, J. M.; Ahmed, R.; Fairlamb, I. J. S.
Tetrahedron Lett. 2002, 43, 8853; (c) Marrison, L. R.;
Dickinson, J. M.; Ahmed, R.; Fairlamb, I. J. S. Bioorg.
Med. Chem. Lett. 2003, 13, 2667.
ꢀ
(b) Kokotos, G.; Constantinou-Kokotou, V.; Padron, J.
M.; Peters, G. J. Bioorg. Med. Chem. Lett. 2001, 11, 861.
42. Dufresne, C.; Wilson, K. E.; Zink, D.; Smith, J.;
Bergstrom, J. D.; Kurtz, M.; Rew, D.; Nallin, M.; Jenkins,